StimCell Enegetics Inc
OTC:STME

Watchlist Manager
StimCell Enegetics Inc Logo
StimCell Enegetics Inc
OTC:STME
Watchlist
Price: 0.32 USD -8.57%
Market Cap: $6.7m

StimCell Enegetics Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

StimCell Enegetics Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
StimCell Enegetics Inc
OTC:STME
Research & Development
$22.5k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Profound Medical Corp
TSX:PRN
Research & Development
-$20.6m
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
-18%
Theralase Technologies Inc
XTSX:TLT
Research & Development
-CA$2.6m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
2%
MedMira Inc
XTSX:MIR
Research & Development
-CA$585.4k
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
5%
O
Ondine Biomedical Inc
LSE:OBI
Research & Development
-CA$9.2m
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Conavi Medical Corp
XTSX:CNVI
Research & Development
-$13m
CAGR 3-Years
34%
CAGR 5-Years
-10%
CAGR 10-Years
10%
No Stocks Found

StimCell Enegetics Inc
Glance View

Market Cap
6.7m USD
Industry
Health Care

StimCell Enegetics Inc is a CA-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2013-03-11. StimCell Enegetics Inc., formerly Cell MedX Corp., is a development stage electroceutical medical device company. The Company’s products include eBalance, and Bio Feedback. The eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms. The biofeedback mechanism is where eBalance offering users and health professionals alike a real-time snapshot of cellular vitality. Its Microcurrent therapy uses molecular bioelectricity in cell-to-cell signaling. Microcurrent is a clinically tested therapy treatment used to treat a range of conditions. There is compelling research in diabetes care, wound therapy, migraine treatment, chronic obstructive pulmonary disease (COPD), and anti-ageing.

STME Intrinsic Value
Not Available

See Also

What is StimCell Enegetics Inc's Research & Development?
Research & Development
22.5k USD

Based on the financial report for May 31, 2024, StimCell Enegetics Inc's Research & Development amounts to 22.5k USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett